In vitro and in vivo response of PSMA-617 radiolabeled with CA and NCA lutetium-177
dc.contributor.author | BOAS, CRISTIAN A.W.V. | pt_BR |
dc.contributor.author | SILVA, JEFFERSON de J. | pt_BR |
dc.contributor.author | DIAS, LUIS A.P. | pt_BR |
dc.contributor.author | FREIRE, MARIA R.B. | pt_BR |
dc.contributor.author | BALIEIRO, LUIZA M. | pt_BR |
dc.contributor.author | SANTOS, CAROLINA S.F. dos | pt_BR |
dc.contributor.author | VIVALDINI, BIANCA F. | pt_BR |
dc.contributor.author | BENEDETTO, RAQUEL | pt_BR |
dc.contributor.author | VIEIRA, DANIEL P. | pt_BR |
dc.contributor.author | PASSOS, PRISCILA de Q.S. | pt_BR |
dc.contributor.author | MARUMO, MARIA H. | pt_BR |
dc.contributor.author | TEIXEIRA, LUIS F.S. | pt_BR |
dc.contributor.author | ARAUJO, ELAINE B. de | pt_BR |
dc.coverage | Internacional | pt_BR |
dc.date.accessioned | 2022-04-13T18:27:50Z | |
dc.date.available | 2022-04-13T18:27:50Z | |
dc.date.issued | 2022 | pt_BR |
dc.description.abstract | The PSMA-targeted radionuclide therapy has been explored since 2015 with radioisotope lutetium-177, whose β− emission range is adequate for micrometastases treatment. This radioisotope is obtained by two different production routes that directly affect the specific activity of lutetium-177 (non-carrier added and carrier added) and, consequently, the specific activity of radiopharmaceuticals, like 177Lu-PSMA-617. The influence of the specific activity of lutetium-177 on the properties of the radiopharmaceutical PSMA-617 was evaluated through pre-clinical studies. The in vitro study pointed to a lower constant of dissociation with non-carrier added lutetium-177 due to the difference in the specific activity. However, competition and internalization assays resulted in similar results for both lutetium-177. Based on these pre-clinical experiments, the total in vitro tumor cell binding and tumor uptake in vivo were similar, with no influence of the specific activity of the 177Lu-PSMA-617. Regardless the specific activity did not directly affect tumor uptake, the tumor/non-target organs ratios were higher for the radiopharmaceutical labeled with carrier added lutetium-177, which had the lowest specific activity. | pt_BR |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | pt_BR |
dc.description.sponsorshipID | FAPESP: 18/12965-4 | pt_BR |
dc.format.extent | 1-7 | pt_BR |
dc.identifier.citation | BOAS, CRISTIAN A.W.V.; SILVA, JEFFERSON de J.; DIAS, LUIS A.P.; FREIRE, MARIA R.B.; BALIEIRO, LUIZA M.; SANTOS, CAROLINA S.F. dos; VIVALDINI, BIANCA F.; BENEDETTO, RAQUEL; VIEIRA, DANIEL P.; PASSOS, PRISCILA de Q.S.; MARUMO, MARIA H.; TEIXEIRA, LUIS F.S.; ARAUJO, ELAINE B. de. In vitro and in vivo response of PSMA-617 radiolabeled with CA and NCA lutetium-177. <b>Applied Radiation and Isotopes</b>, v. 180, p. 1-7, 2022. DOI: <a href="https://dx.doi.org/10.1016/j.apradiso.2021.110064">10.1016/j.apradiso.2021.110064</a>. Disponível em: http://repositorio.ipen.br/handle/123456789/32952. | |
dc.identifier.doi | 10.1016/j.apradiso.2021.110064 | pt_BR |
dc.identifier.issn | 0969-8043 | pt_BR |
dc.identifier.orcid | 0000-0002-0007-534X | pt_BR |
dc.identifier.orcid | https://orcid.org/0000-0003-0456-5589 | |
dc.identifier.orcid | https://orcid.org/0000-0003-2852-6189 | |
dc.identifier.orcid | https://orcid.org/0000-0002-0007-534X | |
dc.identifier.percentilfi | 32.5 | pt_BR |
dc.identifier.percentilfiCiteScore | 46 | pt_BR |
dc.identifier.uri | http://repositorio.ipen.br/handle/123456789/32952 | |
dc.identifier.vol | 180 | pt_BR |
dc.relation.ispartof | Applied Radiation and Isotopes | pt_BR |
dc.rights | openAccess | pt_BR |
dc.subject | prostate | |
dc.subject | membranes | |
dc.subject | antigens | |
dc.subject | lutetium 177 | |
dc.subject | activity levels | |
dc.subject | in vivo | |
dc.subject | in vitro | |
dc.subject | in vitro | |
dc.subject | radiopharmaceuticals | |
dc.subject | neoplasms | |
dc.title | In vitro and in vivo response of PSMA-617 radiolabeled with CA and NCA lutetium-177 | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dspace.entity.type | Publication | |
ipen.autor | MARIA RENATA VALENTE BRANDAO FREIRE | |
ipen.autor | LUIZA MASCARENHAS BALIEIRO | |
ipen.autor | CAROLINA SILVA FERREIRA DOS SANTOS | |
ipen.autor | RAQUEL BENEDETTO | |
ipen.autor | PRISCILA DE QUEIROZ SOUZA PASSOS | |
ipen.autor | LUIZ FELIPE TEIXEIRA DA SILVA | |
ipen.autor | ELAINE BORTOLETI DE ARAUJO | |
ipen.autor | MARIA HELENA BELLINI MARUMO | |
ipen.autor | DANIEL PEREZ VIEIRA | |
ipen.autor | BIANCA FRANCHESQUETI VIVALDINI | |
ipen.autor | LUIS ALBERTO PEREIRA DIAS | |
ipen.autor | JEFFERSON DE JESUS SILVA | |
ipen.autor | CRISTIAN ANTONIO WIECZOREK VILLAS BOAS | |
ipen.codigoautor | 14078 | |
ipen.codigoautor | 11603 | |
ipen.codigoautor | 14584 | |
ipen.codigoautor | 12108 | |
ipen.codigoautor | 14722 | |
ipen.codigoautor | 14146 | |
ipen.codigoautor | 664 | |
ipen.codigoautor | 1242 | |
ipen.codigoautor | 3158 | |
ipen.codigoautor | 14676 | |
ipen.codigoautor | 796 | |
ipen.codigoautor | 14158 | |
ipen.codigoautor | 14503 | |
ipen.contributor.ipenauthor | MARIA RENATA VALENTE BRANDAO FREIRE | |
ipen.contributor.ipenauthor | LUIZA MASCARENHAS BALIEIRO | |
ipen.contributor.ipenauthor | CAROLINA SILVA FERREIRA DOS SANTOS | |
ipen.contributor.ipenauthor | RAQUEL BENEDETTO | |
ipen.contributor.ipenauthor | PRISCILA DE QUEIROZ SOUZA PASSOS | |
ipen.contributor.ipenauthor | LUIZ FELIPE TEIXEIRA DA SILVA | |
ipen.contributor.ipenauthor | ELAINE BORTOLETI DE ARAUJO | |
ipen.contributor.ipenauthor | MARIA HELENA BELLINI MARUMO | |
ipen.contributor.ipenauthor | DANIEL PEREZ VIEIRA | |
ipen.contributor.ipenauthor | BIANCA FRANCHESQUETI VIVALDINI | |
ipen.contributor.ipenauthor | LUIS ALBERTO PEREIRA DIAS | |
ipen.contributor.ipenauthor | JEFFERSON DE JESUS SILVA | |
ipen.contributor.ipenauthor | CRISTIAN ANTONIO WIECZOREK VILLAS BOAS | |
ipen.date.recebimento | 22-04 | |
ipen.identifier.fi | 1.6 | pt_BR |
ipen.identifier.fiCiteScore | 2.9 | pt_BR |
ipen.identifier.ipendoc | 28654 | pt_BR |
ipen.identifier.iwos | WoS | pt_BR |
ipen.identifier.ods | 3 | |
ipen.range.fi | 1.500 - 2.999 | |
ipen.range.percentilfi | 25.00 - 49.99 | |
ipen.type.genre | Artigo | |
relation.isAuthorOfPublication | 4a2cf3e5-b1e3-4acb-b557-59f05043a6c5 | |
relation.isAuthorOfPublication | 405bc37a-8db8-4e93-9cb7-7069e83c524f | |
relation.isAuthorOfPublication | 600a15d7-f100-43f9-af66-8dee344157eb | |
relation.isAuthorOfPublication | 3a83a165-5db9-4e4b-9c68-1c1cf0c9fc78 | |
relation.isAuthorOfPublication | be35124f-007e-45eb-ba9d-2eba9d9b176d | |
relation.isAuthorOfPublication | 1ccbe3d6-1fec-40ee-9090-54f8ccd43c4d | |
relation.isAuthorOfPublication | ca74886d-6974-47a8-9308-c4cc39bb6e35 | |
relation.isAuthorOfPublication | 6a450cbf-91b1-4386-b4a8-7304afac99cc | |
relation.isAuthorOfPublication | c2352608-be9c-4a73-be8c-571f10bb53d2 | |
relation.isAuthorOfPublication | 53528060-2ca0-4c70-98d1-af92cff00b89 | |
relation.isAuthorOfPublication | 50b3adab-a651-4225-a05c-ec1b1e37e921 | |
relation.isAuthorOfPublication | e8000cb1-6652-4f0d-b495-e69f2ec951c1 | |
relation.isAuthorOfPublication | df5938f0-d4f2-4973-88b2-c61febb4d3bf | |
relation.isAuthorOfPublication.latestForDiscovery | df5938f0-d4f2-4973-88b2-c61febb4d3bf | |
sigepi.autor.atividade | ARAUJO, ELAINE B. de:664:130:N | pt_BR |
sigepi.autor.atividade | TEIXEIRA, LUIS F.S.:14146:810:N | pt_BR |
sigepi.autor.atividade | MARUMO, MARIA H.:1242:810:N | pt_BR |
sigepi.autor.atividade | PASSOS, PRISCILA de Q.S.:14722:810:N | pt_BR |
sigepi.autor.atividade | VIEIRA, DANIEL P.:3158:810:N | pt_BR |
sigepi.autor.atividade | BENEDETTO, RAQUEL:12108:110:N | pt_BR |
sigepi.autor.atividade | VIVALDINI, BIANCA F.:14676:110:N | pt_BR |
sigepi.autor.atividade | SANTOS, CAROLINA S.F. dos:14584:110:N | pt_BR |
sigepi.autor.atividade | BALIEIRO, LUIZA M.:11603:110:N | pt_BR |
sigepi.autor.atividade | FREIRE, MARIA R.B.:14078:110:N | pt_BR |
sigepi.autor.atividade | DIAS, LUIS A.P.:796:120:N | pt_BR |
sigepi.autor.atividade | SILVA, JEFFERSON de J.:14158:-1:N | pt_BR |
sigepi.autor.atividade | BOAS, CRISTIAN A.W.V.:14503:110:S | pt_BR |